Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for treatment of serious diseases with significant unmet medical needs in the orphan drug segment

 

 

 

Upcoming event

Latest presentation

Latest Report

August 19, 2022

Q2 Report 2022

Calendar and upcoming reports

October 13, 2022

Capital Markets Day

November 8, 2022

Interim report January - September

November 21-23, 2022

SEB Life Science Summit

Share

Twitter
LinkedIn

Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: info@egetis.com